Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Assets    
Equity method investments $ 458,267 $ 471,044
Real estate 363,809 365,370
Investments 124,370 169,793
Cash and cash equivalents 37,892 21,418
Other assets 192,191 182,628
Total Assets 2,027,421 2,154,913
Liabilities:    
Accounts payable, accrued expenses and other 38,264 36,509
Deferred funding obligations 5,814 72,100
Credit facilities 209,653 258,592
Non-recourse debt (secured by assets of $920 million and $1,105 million, respectively) 740,003 834,738
Convertible notes 148,943 148,451
Total Liabilities 1,142,677 1,350,390
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 64,912,741 and 60,510,086 shares issued and outstanding, respectively 649 605
Additional paid in capital 1,060,086 965,384
Accumulated deficit (180,217) (163,205)
Accumulated other comprehensive income (loss) 968 (1,684)
Non-controlling interest 3,258 3,423
Total Stockholders’ Equity 884,744 804,523
Total Liabilities and Stockholders’ Equity 2,027,421 2,154,913
Government Receivables [Member]    
Assets    
Receivables 342,606 497,464
Commercial Receivables [Member]    
Assets    
Receivables $ 508,286 $ 447,196